Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Classification of patients with chronic myeloid leukemia on basis of BCR-ABL transcript level at 3 months fails to identify patients with low organic cation transporter-1 activity destined to have poor imatinib response|
|Citation:||Journal of Clinical Oncology, 2012; 2012(10):1144-1145|
|Publisher:||Amer Soc Clinical Oncology|
|Deborah L. White and Timothy P. Hughes|
|Keywords:||Humans; Leukemia, Myeloid, Chronic-Phase; Piperazines; Pyrimidines; Fusion Proteins, bcr-abl; Female; Male; Protein-Tyrosine Kinases|
|Rights:||© 2012 by American Society of Clinical Oncology|
|Appears in Collections:||Medicine publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.